Advancing Liquid Biopsy Techniques – Asian Scientist Magazine

Liquid biopsy is becoming more popular as a way to detect and diagnose cancer. It is a minimally invasive procedure that involves screening biofluid samples for biomarkers, including cell-free DNA. Twist Bioscience has developed a kit to help with sequencing cell-free DNA for better detection of cancer-related biomarkers. This kit offers higher yields, better coverage, and more sensitive detection of low-frequency variants. It is especially useful for detecting circulating tumor DNA, which can provide valuable information for cancer prognosis and diagnosis. The kit has been well-received by clinicians and researchers, offering improved coverage and faster turnaround times. It also comes with a reference standard to track the quality of the sequencing process. These advancements in liquid biopsy technology show Twist Bioscience’s commitment to improving cancer research and personalized therapy.



Source link